Aster DM Healthcare Ltd.
Snapshot View

160.05 -0.20 ▼-0.1%

23 July 2021, 04:00:00 P.M.
Volume: 18,260

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.asterdmhealthcare.com
Financial Indicators
Market Cap 7,982.22 Cr.
Earnings per share (EPS) 2.96 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 54.03 Trailing Twelve Months Ending 2021-03
Industry PE 223.80 Trailing Twelve Months Ending 2021-03
Book Value / Share 67.56 Trailing Twelve Months Ending 2021-03
Price to Book Value 2.37 Calculated using Price: 159.80
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 49.95 Cr. 499,513,060 Shares
FaceValue 10
Company Profile

The company was incorporated on January 18, 2008 as ‘DM Healthcare Private Limited’ at Kochi, Ernakulam, Kerala as a private limited company under the Companies Act, 1956. The name of company was changed to ‘Aster DM Healthcare Private Limited’ and a fresh certificate of incorporation consequent upon change of name was issued on November 29, 2013. Subsequently, the company was converted into a public company pursuant to special resolution passed by shareholders on November 10, 2014 and the name of the company was changed to ‘Aster DM Healthcare Limited’ a Fresh Certificate of Incorporation consequent upon conversion to public limited Company dated on January 1, 2015.

The company is one of the largest private healthcare service providers which operate in multiple GCC states based on numbers of hospitals and clinics. It currently operate in all of the GCC states, which comprise the United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait and Bahrain, in Jordan, in India and the Philippines. Its GCC operations are headquartered in Dubai, United Arab Emirates and Indian operations are headquartered in Kochi, Kerala. The company has a diversified portfolio of healthcare facilities, consisting of 9 hospitals, 90 clinics and 206 retail pharmacies in the GCC states, 10 multi-specialty hospitals and 7 clinics in India, and 1 clinic in the Philippines as of September 30, 2017.

Business area of the company

The company operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provide healthcare services to patients across economic segments in several GCC states through its various brands “Aster”, “Medcare” and “Access”. A majority of its hospitals and clinics provide secondary and tertiary healthcare services to patients. In addition to providing core medical, surgical and emergency services, some of its hospitals provide complex and advanced quaternary healthcare in various specialties, including cardiology, oncology, radiology, ophthalmology, neurosciences, paediatrics, gastroenterology, orthopaedics and critical care services.

Awards and achievements

  • 2001: MIMS Hospital, Kozhikode, India received the first place (certificate of merit) from the Kerala State Pollution Control Board for making a substantial and sustained effort in pollution control. MIMS subsequently received this certificate of merit in 2007, 2008, 2009, 2010, 2011, 2012 and 2013 for various hospitals.
  • 2006: MIMS Hospital, Kozhikode, India received NABH accreditation valid upto October 29, 2009 which was subsequently renewed up to October 29, 2018.
  • 2012: MIMS Laboratory Services, MIMS received ISO 15189:2007 certification in the field of Medical Testing valid up to October 8, 2016, which was subsequently renewed as ISO 15189:2012 up to October 8, 2018.
  • 2013: Medcare Hospital LLC, Dubai, UAE received JCI accreditation valid up to December 21, 2016, which was subsequently renewed up to November 10, 2019.
  • 2014: Aster Pharmacy Group received the Best Service Performance Brand Award by Dubai Service Excellence Scheme.
  • 2015: Aster Medcity, Kochi, India received NABH accreditation for compliance with the Certification Standards for Nursing Excellence valid up to March 30, 2017 which was subsequently renewed up to March 30, 2019.
  • 2015: Aster Medcity, Kochi, India received the ISO 22000:2005 certification for production and service of food for patients, staff and patients’ relatives within the hospital from Bureau Veritas Certification Holding SAS – UK Branch, valid up to July 16, 2018.
  • 2015: The company received the ‘National Awards for Excellence in Healthcare Award for Best Marketing Campaign – Healthcare Industry’ by CMO Asia.
  • 2016: The company received the ‘Institutional Bravery Award’ for Distinguished Service in Flood Relief in Chennai and Cuddalore, 2015 by the Society for Emergency Medicine India.
  • 2016: Aster Pharmacies Group received the Dubai Quality Appreciation Award for 2016 from the Government of Dubai.
  • 2016: Aster Pharmacy received the Best Service Performance Brand Award by Dubai Service Excellence Scheme.
  • 2017: Aster CMI hospital received the ‘Best Hospitality in Healthcare’ award from the Times Network.
  • 2017: Aster CMI hospital has been ranked as the 23rd best multi specialty hospital (national rankings), 7th best multi specialty hospital (South India) and 2nd best multi specialty hospital in Bangalore in the All India Multispecialty Hospital Ranking Survey 2017 by the Times Group.
  • 2017: Aster CMI hospital has been ranked 11th in gastroenterology and hepatology (South India) and 3rd in gastroenterology and hepatology in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group.
  • 2017: Aster CMI hospital has received the ‘CMO Asia Presents Asia Healthcare Excellence Award’ in the ‘best hospitality in healthcare’ category.
  • 2018: Aster DM Healthcare wins Special Recognition at Arabia CSR Awards 2018.
  • 2018: Aster Pharmacy & Aster Hospital win Dubai Business Excellence Awards.
  • 2019: Aster DM Healthcare wins four Dubai Business Excellence Awards.
  • 2019: Aster Volunteers CSR Award PR.
  • 2019: Aster DM Healthcare bags Gulf Business Awards-2017 for the 'Healthcare Company of the Year' Category.
  • 2020: Aster MIMS Kottakkal conferred Six Sigma Healthcare Excellence Award.
  • 2020: Aster DM Healthcare wins 6 awards at AHPI Awards 2020

Major Events

  • 1987: The company’s Promoter, Dr. Azad Moopen started a clinic in Dubai.
  • 1995: First specialty medical centre was launched in Dubai.
  • 2001: MIMS Kozhikode Hospital commenced operations.
  • 2005: Al Rafa Hospital for Maternity and Surgery (now called Aster Day Surgery Centre LLC) commenced operations.
  • 2006: Medcare Hospital, commenced operations.
  • 2008: The company acquired majority stake in PHL, Kolhapur.
  • 2009: Al Raffah Hospital, first hospital in Oman, commenced operations in Muscat.
  • 2010: The company acquired 100% of the paid up equity share capital of Affinity, Mauritius.
  • 2010: Al Raffah Hospital, second hospital in Oman, commenced operations in Sohar. 
  • 2011: Second Medcare Hospital, namely Medcare Orthopedics and Spine Hospital (Dubai) commenced operations.
  • 2013: The company acquired 60.35% of the paid up equity share capital of IHPL and consequently MIMS became its Subsidiary.
  • 2014: The company acquired hospital operational and management rights in Aster CMC, Bangalore pursuant to the hospital operation and management agreement dated May 12, 2014.
  • 2014: The company acquired 54% stake in Aster Kuwait and 51% stake in Orange Pharmacies LLC, Jordan.
  • 2015: First clinic in the Kingdom of Bahrain commenced operations; first clinic in the Philippines commenced operations.
  • 2016: The company divested its stake in Medipoint Hospitals Private Limited, Pune.
  • 2016: The company acquired 51% stake in Dr Ramesh Hospital.
  • 2016: Second clinic in Bahrain commences operations.
  • 2016: Medcare Women and Child Hospital in Dubai was launched.
  • 2017: Entered into an operation and management agreement with the Rashtreeya Sikshana Samithi Trust to operate and manage a hospital in Bengaluru.
  • 2017: Medare Hospital Sharjah and Aster Hospital Doha commenced operations.
  • 2018: Aster DM Healthcare partners with Nigerian University Hospital to provide advanced healthcare solutions.
  • 2018: Aster Pharmacy launches its First Eco-Friendly Pharmacy in UAE.
  • 2018: Sharjah Health Authority signs MoU with Aster DM Healthcare to expand healthcare coverage for residents.
  • 2019: Aster DM Healthcare hikes shareholding in Prerana Hospital to 86.99%.
  • 2019: Aster DM Healthcare hikes stake in Sri Sainatha Multispeciality Hospital.
  • 2020: Aster DM Healthcare collaborates with Social Alpha.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-0.12%
1 Week
+0.31%
1 Month
+4.47%
3 Month
+8.03%
6 Month
-0.06%
1 Year
+19.66%
2 Year
+28.09%
5 Year
6 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 18.33 0.95 8.52 11.87 12.16 9.71
Return on Capital Employed (%) 15.42 7.71 11.45 10.38 11.01 11.77
Return on Assets (%) 6.17 0.18 1.56 3.91 4.48 2.95

Balance Sheet View Details

Particulars 6 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 1,484 420 1,875 2,832 3,214 3,272
Non Curr. Liab. 924 3,180 2,352 2,066 2,581 4,965
Curr. Liab. 1,239 1,967 2,201 2,224 2,668 3,722
Minority Int. 762 177 375 358 466 446
Equity & Liab. 4,409 5,743 6,804 7,479 8,928 12,405
Non Curr. Assets 2,609 3,237 4,332 4,610 5,311 8,310
Curr. Assets 1,801 2,506 2,472 2,869 3,617 4,096
Misc. Exp. not W/O
Total Assets 4,409 5,743 6,804 7,479 8,928 12,405

Profit Loss View Details

Particulars 6 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 3,876 5,250 5,931 6,721 7,963 8,739
Other Income 23 25 37 45 35 38
Total Income 3,899 5,275 5,968 6,767 7,997 8,776
Total Expenditure -3,358 -4,789 -5,582 -6,089 -7,074 -7,450
PBIDT 541 486 386 678 924 1,327
Interest -91 -205 -371 -204 -205 -391
Depreciation -144 -243 -322 -298 -306 -586
Taxation -34 -29 -11 -26 -43 -15
Exceptional Items 416 130 -2 -20
PAT 272 9 98 279 368 315

Cash Flow View Details

Particulars 6 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 236 203 361 537 601 1,223
Cash Fr. Inv. -448 -786 -1,153 -523 -709 -667
Cash Fr. Finan. 203 578 654 46 134 -675
Net Change -10 -5 -138 61 26 -119
Cash & Cash Eqvt 248 253 131 192 225 115

Shareholding Pattern View Details

9 Qtrs 2019-03 (%) 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%)
Promoter 37.80 37.80 37.80 37.80 37.87 37.88 37.88 37.88 37.88
Public 61.60 62.20 62.20 62.20 62.13 61.57 61.57 62.12 62.12
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.44

Announcements View Details

Thu, 22 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of newspaper advertisements titled Notice of 13th Annual General Meeting that appeared in todays edition in Financial Express (English Language) and Vijayavani (Kannada Language).

This information will also be made available on our website at the following link: http://www.asterdmhealthcare.com/investors.
Wed, 21 Jul 2021
Notice Of The 13Th Annual General Meeting (AGM) And Annual Report For Financial Year 2020-21
With reference to captioned subject we wish to inform that the 13th AGM of Aster DM Healthcare Limited ("the Company") is scheduled to be held on Friday August 13 2021 at 11:30 A.M (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM) to transact the businesses as set forth in the Notice of AGM.

Pursuant to Regulation 34 of the SEBI (LODR) Regulations 2015 please find enclosed the Notice of the 13th Annual General Meeting and the Annual Report for the financial year 2020-21.

In compliance with the MCA Circulars and SEBI Circulars the Notice of the 13th AGM along with the Annual Report for the FY 2020-21 are being sent only through electronic mode to those Members whose email IDs are registered with the Company/ Depositories. Further the same are also made available on the website of the Company at www.asterdmhealthcare.com/investors/.

We request you to take the same on record.
Wed, 21 Jul 2021
Reg. 34 (1) Annual Report
With reference to captioned subject we wish to inform that the 13th AGM of Aster DM Healthcare Limited ("the Company") is scheduled to be held on Friday August 13 2021 at 11:30 A.M (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM) to transact the businesses as set forth in the Notice of AGM.

Pursuant to Regulation 34 of the SEBI (LODR) Regulations 2015 please find enclosed the Notice of the 13th Annual General Meeting and the Annual Report for the financial year 2020-21.

In compliance with the MCA Circulars and SEBI Circulars the Notice of the 13th AGM along with the Annual Report for the FY 2020-21 are being sent only through electronic mode to those Members whose email IDs are registered with the Company/ Depositories. Further the same are also made available on the website of the Company at www.asterdmhealthcare.com/investors/.

We request you to take the same on record.

Technical Scans View Details

Fri, 23 Jul 2021
Decreasing Relative Strength - Benchmark index Decreasing Relative Strength - Benchmark index
Decreasing Relative Strength - Sectoral index Decreasing Relative Strength - Sectoral index
Close Within 2 Year High Zone Close Within 2 Year High Zone
Both SRS And ARS Below Zero Both SRS And ARS Below Zero
MACD Crossing Signal Line From Above MACD Crossing Signal Line From Above

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 166,513.85 694.00 +1.0%
Divi's Laboratories Ltd. 128,088.59 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. 90,175.51 5,420.50 +0.7%
Cipla Ltd. 76,510.04 948.50 -0.1%
Cadila Healthcare Ltd. 62,965.29 615.05 -0.9%
Aurobindo Pharma Ltd. 56,484.48 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. 56,291.69 3,915.00 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 57.34 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 64.55 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.21 5,420.50 +0.7%
Cipla Ltd. Consolidated 2021-03 31.81 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 29.51 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.59 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 374.38 3,915.00 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.58 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 13.78 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.15 5,420.50 +0.7%
Cipla Ltd. Consolidated 2021-03 4.17 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 4.85 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.58 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.25 3,915.00 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 0.18 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 3,915.00 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 10.09 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 3,915.00 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 12.53 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 3,915.00 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 17,131.99 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 3,915.00 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 1,546.98 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 3,915.00 -1.8%